Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
Open Access
- 15 February 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 13 (1), 78
- https://doi.org/10.1186/1471-2407-13-78
Abstract
Accumulating evidence indicates that components of the systemic inflammatory response, such as C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), have been associated with prognosis of various cancers. We aimed to elucidate whether CRP and NLR could serve as potential surrogate markers for response and survival in patients with hepatocellular carcinoma (HCC).This publication has 34 references indexed in Scilit:
- Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation MarkersTransplantation, 2011
- Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer PatientsAnnals of Surgical Oncology, 2011
- Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancerJournal of Surgical Oncology, 2011
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancerFuture Oncology, 2010
- Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanismsInternational Journal of Cancer, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis: Integrative Cancer Research, 2009
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studiesLiver International, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Serum C‐reactive protein levels predict survival in hepatocellular carcinomaLiver International, 2007
- Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: An in vitro studyJournal of Gastroenterology and Hepatology, 2005